Volume 9, Number 6—June 2003
Clinical Implications of Varying Degrees of Vancomycin Susceptilibity in Methicillin-Resistant Staphylococcus aureus Bacteremia1
|Antibiotic exposure||Cases n=58 (%)||Controls n=84 (%)||p value|
|Administration of any antibiotic||27 (47)||45 (54)||0.50|
|Administration of vancomycin||10 (17)||14 (17)||1.00|
|Number of days receiving vancomycin (mean)||1.2±4.8||1.0±3.5||0.88|
1Presented in part at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, December 2001.
Page created: December 22, 2010
Page updated: May 30, 2012
Page reviewed: May 30, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.